Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bloodless glucose measurements

J N Roe1, B R Smoller

  • 1Amira Medical, Inc., Palo Alto, CA 94303-4310, USA.

Critical Reviews in Therapeutic Drug Carrier Systems
|August 12, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bullous pemphigoid associated with nivolumab, a programmed cell death 1 protein inhibitor.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Histological study of necrolytic acral erythema.

The Journal of the Arkansas Medical Society·2004
Same author

Leukocytoclastic (small vessel) vasculitis in multiple myeloma.

Clinical and experimental dermatology·2003
Same author

Sweet syndrome in multiple myeloma: a series of six cases.

Journal of cutaneous pathology·2003
Same author

AL amyloidosis is not present as an incidental finding in cutaneous biopsies of patients with multiple myeloma.

Clinical and experimental dermatology·2002
Same author

Granuloma annulare: another manifestation of Bartonella infection?

The American Journal of dermatopathology·2002
Same journal

Unveiling the Potential of Drug Delivery Systems for Tyrosine Kinase Inhibitors in the Treatment of Neovascular Eye Diseases.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Investigation of Bioinspired Nanocurcumin Composites for Antibacterial Applications.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Advances in the Preparation of Lipid-Based Nanotechnologies: Expanding the Horizons of Therapeutic Applications.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Nano Lipid Carriers (NLCs): Potential and Promises in Drug Delivery.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

CpG ODNs: Precision Immunotherapy and Recent Trends in Nano-Enabled Nucleotide Delivery.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Plant-Based Exosomes: Insights and Therapeutic Applications.

Critical reviews in therapeutic drug carrier systems·2026
See all related articles

Painful finger pricks discourage daily blood glucose monitoring for diabetes patients. New painless glucose monitoring techniques using alternative body fluids are under development to improve diabetes management and reduce complications.

Area of Science:

  • Endocrinology
  • Biomedical Engineering
  • Medical Technology

Background:

  • Self-monitoring of blood glucose is crucial for diabetes management and treatment decisions.
  • Current guidelines recommend frequent testing (4-6 times daily) for insulin-dependent diabetes to prevent complications.
  • Low adherence to frequent testing is common due to the pain associated with traditional finger-prick blood sampling.

Purpose of the Study:

  • To review current research and development in painless glucose-monitoring techniques.
  • To explore the potential of using alternative body fluids for glucose measurement.
  • To highlight advancements that could revolutionize diabetes treatment.

Main Methods:

  • Review of existing and emerging glucose-monitoring technologies.

Related Experiment Videos

  • Analysis of methods utilizing body fluids beyond blood.
  • Assessment of pain reduction strategies in glucose testing.

    • Main Results:

    • Several glucose-monitoring techniques are being investigated for painless or near-painless application.
    • The use of alternative body fluids shows promise for non-invasive or minimally invasive glucose measurement.
    • Technological advancements are paving the way for improved patient compliance and disease management.

    Conclusions:

    • Painless glucose monitoring is a critical area of research for improving diabetes care.
    • New technologies utilizing alternative body fluids could significantly enhance patient adherence and outcomes.
    • Further development in this field holds revolutionary potential for the treatment of diabetes.